|
Proleukin in Combination with Rituxan in Patients with Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan Treatments Clinical Trials Resources presented on Clinical Trials Search is not meant to be a substitute for proven health advice, calls or treatment with a real medical. We aren't mDs. Always consult your doctor on Proleukin in Combination with Rituxan in Patients with Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan Treatments conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. Proleukin in Combination with Rituxan in Patients with Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan Treatments Clinical research trials and Proleukin in Combination with Rituxan in Patients with Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan Treatments healthcare trials take place in a lot of of localities throughout the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically assess the effectiveness of new does drugs. The function of the studies / projects is to figure out specific human medical questions. Clinical trials are a popular means for doctors, government agencies, and private sector corporations to find cures for all varieties of conditions, like Proleukin in Combination with Rituxan in Patients with Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan Treatments. Proleukin in Combination with Rituxan in Patients with Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan Treatments Clinical Trials and other clinical trials allow volunteers to access health treatment options before they are available to the masses. Many times the subjects receive professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a Proleukin in Combination with Rituxan in Patients with Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan Treatments clinical trial. Human subjects often obtain the finest healthcare possible for their Proleukin in Combination with Rituxan in Patients with Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan Treatments condition. Hazards are a reality, nevertheless, and might include additional or frequent dr. calls, health hazards (potentially life-jeopardizing), and/or the treatment being uneffective. Trials are federally regulated with stern guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "P" Clinical Trials Conditions > Proleukin in Combination with Rituxan in Patients with Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan Treatments Proleukin in Combination with Rituxan in Patients with Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan Treatments
Proleukin in Combination with Rituxan in Patients with Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan Treatments
For Condition: Lymphoma, Non-Hodgkin
Status: Recruiting
Sponsor(s): Chiron Corporation ,
Synopsis: The purpose of this study is to determine the safety and effectiveness of combination therapy with Proleukin and Rituxan on patients with low-grade Non-Hodgkin's Lymphoma who have previously failed Rituxan treatments.
Details:
Eligibility:
Study Type: Interventional, Treatment
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Diagnosis and disease status: - Subjects with CD20+, B-cell, Non-Hodgkin's lymphoma of low-grade or follicular histology with measurable relapsed or unresponsive disease after prior therapy; mantle cell and chronic lymphocytic leukemia subtypes are excluded. - Subjects who previously received a single-agent course of rituximab and showed no tumor response, or had a response lasting < 6 months. The previously administered rituximab must have included at least 75% of the standard 4-week regimen (4 x 375 mg/m2). A record of the previous rituximab treatment and response must be available as a source document at the site. Exclusion: - Subjects who showed no tumor response or a response lasting <6 months to treatment with Rituximab in combination with Chemotherapy or another therapeutic modality (radiation or radioimmunoconjugates). - HIV positive. - Symptomatic thyroid disease requiring medical intervention other than replacement treatment for hypothyroidism. - Clinically significant cardiac, pulmonary, and /or hepatic dysfunction (if subject has history of congestive heart failure or myocardial infarction, must have been stable for at least 6 months, and have no current symptoms - If cardiac ejection fraction has been measured, it must be greater than 50%.
Total Enrollment:
Location and Contact Information:
Facey Medical Foundation *Recruiting*
Mission Hills, California, 91345
United States
Recruiting
Washington Cancer Institute *Recruiting*
Washington D.C., District of Columbia, 20010
United States
Recruiting
Mount Sinai School of Medicine *Recruiting*
New York City, New York, 10029
United States
Recruiting
North Valley Hematology-Oncology Medical Group *Recruiting*
Mission Hills, California, 91345
United States
Recruiting
Gabrail Cancer Center *Recruiting*
Canton, Ohio, 44718
United States
Recruiting
Oregon Health & Science University *Recruiting*
Portland, Oregon, 97201
United States
Recruiting
Comprehensive Blood and Cancer Center *Recruiting*
Bakersfield, California, 93309
United States
Recruiting
California Oncology of the Central Valley *Recruiting*
Fresno, California, 93710
United States
Recruiting
San Diego Cancer Center Medical Group *Recruiting*
Vista, California, 92083
United States
Recruiting
Hoag Cancer Center *Recruiting*
Newport Beach, California, 92658
United States
Recruiting
Pacific Shores Medical Group *Recruiting*
Glendale, California, 91204
United States
Recruiting
Whittingham Cancer Center *Recruiting*
Norwalk, Connecticut, 06856
United States
Recruiting
Sansum Santa Barbara Foundation Medical Clinic *Recruiting*
Santa Barbara, California, 93105
United States
Recruiting
Santa Barbara Hematology Oncology Medical Group, Inc. *Recruiting*
Santa Barbara, California, 93105
United States
Recruiting
Virginia K. Crosson Cancer Center *Recruiting*
Fullerton, California, 92835
United States
Recruiting
Wilshire Oncology Medical Group *Recruiting*
Glendora, California, 91741
United States
Recruiting
Wilshire Oncology Medical Group *Recruiting*
West Covina, California, 91790
United States
Recruiting
Wilshire Oncology Medical Group *Recruiting*
Pasadena, California, 91105
United States
Recruiting
Northern New Jersey Cancer Associates *Recruiting*
Hackensack, New Jersey, 07601
United States
Recruiting
Virginia Cancer Institute *Recruiting*
Richmond, Virginia, 23230
United States
Recruiting
Cancer Centers of the Carolinas *Recruiting*
Greenville, South Carolina, 29605
United States
Recruiting
UC Davis Cancer Center *Recruiting*
Sacramento, California, 95817
United States
Recruiting
Cancer Care Associates Medical Group, Inc. *Recruiting*
Torrance, California, 90505
United States
Recruiting
Louisiana State University Health Sciences Center and VA *Recruiting*
Shreveport, Louisiana, 71130
United States
Recruiting
Ventura County Hematology-Oncology Specialists *Recruiting*
Ventura, California, 93003
United States
Recruiting
Weill Medical College of Cornell University/New York Presbyterian Hospital *Recruiting*
New York City, New York, 10021
United States
Recruiting
Benefis Healthcare *Recruiting*
Great Falls, Montana, 59405
United States
Recruiting
City of Hope National Medical Center *Recruiting*
Duarte, California, 91010
United States
Recruiting
Cancer Care Center *Recruiting*
Bloomington, Indiana, 47403
United States
Recruiting
University of Iowa Hospitals and Clinics *Recruiting*
Iowa City, Iowa, 52242
United States
Recruiting
Duke University Medical Center, Morris Cancer Clinic *Recruiting*
Durham, North Carolina, 27710
United States
Recruiting
Indiana University Medical Center *Recruiting*
Indianapolis, Indiana, 46202
United States
Recruiting
Maine Center for Cancer Medicine & Blood Disorders *Recruiting*
Scarborough, Maine, 04074
United States
Recruiting
ACRC/Arizona Clinical Research Center, Inc. *Recruiting*
Tucson, Arizona, 85712
United States
Recruiting
Pacific Shores Medical Group *Recruiting*
Los Alamitos, California, 90720
United States
Recruiting
East Carolina University School of Medicine, Department of Medicine, Division of Hematology/Oncology *Recruiting*
Greenville, North Carolina, 27858-4354
United States
Recruiting
Wilshire Oncology Medical Group *Recruiting*
Pomona, California, 91767
United States
Recruiting
Division of Hematology/Oncology, University of Miami, School of Medicine *Recruiting*
Miami, Florida, 33136
United States
Recruiting
Cancer Care Associates Meidcal Group, Inc. *Recruiting*
Redondo Beach, California, 90277
United States
Recruiting
Ventura County Hematology-Oncology Specialists *Recruiting*
Oxnard, California, 93030
United States
Recruiting
Hematology and Oncology Specialists, LLC *Recruiting*
New Orleans, Louisiana, 70115
United States
Recruiting
North Valley Hematology/Oncology Medical Group *Recruiting*
Northridge, California, 91328
United States
Recruiting
Oncology Specialists,S.C. *Recruiting*
Park Ridge, Illinois, 60068
United States
Recruiting
John Wayne Cancer Institute *Recruiting*
Santa Monica, California, 90404
United States
Recruiting
Hematology Oncology Consultants, Inc. *Recruiting*
Columbus, Ohio, 43235
United States
Recruiting
Comprehensive Cancer Centers of Nevada *Recruiting*
Las Vegas, Nevada, 89109
United States
Recruiting
Pacific Shores Medical Group *Recruiting*
Huntington Beach, California, 92648
United States
Recruiting
California Cancer Care Inc. *Recruiting*
Greenbrae, California, 94904
United States
Recruiting
Santa Barbara Hematology Oncology Medical Group *Recruiting*
Lompoc, California, 93438
United States
Recruiting
Consultants in Blood Disorders and Cancer *Recruiting*
Louisville, Kentucky, 40207
United States
Recruiting
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute *Recruiting*
Columbus, Ohio, 43210
United States
Recruiting
Wilshire Oncology Medical Group *Recruiting*
Rancho Cucamonga, California, 91730
United States
Recruiting
Pacific Shores Medical Group *Recruiting*
Long Beach, California, 90813
United States
Recruiting
Northwestern University Medical School *Recruiting*
Chicago, Illinois, 60611
United States
Recruiting
Fletcher Allen Health Care *Recruiting*
Burlington, Vermont, 05401
United States
Recruiting
UCLS Medical Center *Recruiting*
Los Angeles, California, 90095
United States
Recruiting
Kansas City Oncology and Hematology Group *Recruiting*
Kansas City, Missouri, 64111
United States
Recruiting
UCLA Medical Group/Pasadena Oncology *Recruiting*
Pasadena, California, 91105
United States
Recruiting
Germantown Cancer Foundation *Recruiting*
Germantown, Tennessee, 38138
United States
Recruiting
Santa Barbara Hematology Oncology Medical Group *Recruiting*
Solvang, California, 93463
United States
Recruiting
Santa Barbara Hematology Oncology Medical Group *Recruiting*
Santa Maria, California, 93454
United States
Recruiting
Advanced Oncology Associates *Recruiting*
New Rochelle, New York, 10801
United States
Recruiting
Indiana Oncology and Hematology Consultants *Recruiting*
Indianapolis, Indiana, 46202
United States
Recruiting
Southwest Cancer Care *Recruiting*
Poway, California, 92064
United States
Recruiting
The Cleveland Clinic Foundation *Recruiting*
Cleveland, Ohio, 44195
United States
Recruiting
Comprehensive Cancer Centers of Nevada *Recruiting*
Henderson, Nevada, 89052
United States
Recruiting
UCLA/Santa Clarita Valley Cancer Center *Recruiting*
Valencia, California, 91355
United States
Recruiting
Additional Information:
Study ID Numbers: IL2NHL03;
Study Start Date:
Record last reviewed: June 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00045877
Other Lymphoma, Non-Hodgkin Studies:
1. The Use of Chemotherapy Plus Radiotherapy Plus Azidothymidine in Patients with AIDS-Related Lymph Node Cancer
2. Meaning-Centered Psychotherapy in Advanced Cancer
3. Evaluation of Bay 59-8862 in Patients with Aggressive, Refractory Non-Hodgkin's Lymphoma
4. A Study of Azidothymidine (AZT) in the Treatment of HIV Infection in Patients Receiving a Bone Marrow Transplant
5. Music Imagery for Patients Receiving Chemotherapy for Leukemia or Non-Hodgkin’s Lymphoma
Related Studies:
Other Lymphoma, Non-Hodgkin Clinical Trials
Other District of Columbia Clinical Trials
Other Washington D.C. Clinical Trials
Proleukin in Combination with Rituxan in Patients with Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan Treatments
|
|
|
|
|
|
|
|